Discrimination of tuberculous from carcinomatous pleural effusion by biochemical markers: adenosine deaminase, lysozyme, fibronectin and carcinoembryonic antigen.

作者: Yuji MORIWAKI , Naoyoshi KOHJIRO , Masami ITOH , Yuji NAKATSUJI , Mutsumi OKADA

DOI: 10.2169/INTERNALMEDICINE1962.28.478

关键词: PathologyEffusionPleural effusionDifferential diagnosisLysozymeMedicineCarcinomaCarcinoembryonic antigenFibronectinAdenosine deaminase

摘要: We measured adenosine deaminase (ADA), lysozyme, fibronectin and carcinoembryonic antigen (CEA) in the pleural fluid of tuberculous carcinomatous effusion order to discriminate these two groups. Tuberculous had significantly higher levels ADA lysozyme than did effusion. When activity more 33 IU/ι is considered, diagnostic tests effusions showed a sensitivity 100%, specificity 95% accuracy 96%. A fluid/serum ratio (pl-ADA/s-ADA) above 1.1 was found 100% 53% (sensitivity 47%, 70%). level 12 μg/ml, selected as discriminating limit, 17% 83%, 88%). Pleural (PL/SL) also valuable discrimination cut-off 1.2 88% 93%, respectively. The mean concentration with that effusion, but there marked overlap between On other hand, CEA effusions. At 5 ng/ml, patients elevated levels, while none 53%, 65%). combined assay ADA, pl-ADA/s-ADA, PL/SL provide information differential diagnosis can not be considered have definite value.

参考文章(17)
M Klockars, T Pettersson, T Vartio, H Riska, A Vaheri, Fibronectin in exudative pleural effusions. Journal of Clinical Pathology. ,vol. 35, pp. 723- 727 ,(1982) , 10.1136/JCP.35.7.723
Shinsuke Tamura, Tetsuya Nishigaki, Yuji Moriwaki, Hiroshi Fujioka, Takashi Nakano, Junji Fujii, Tetsuya Yamamoto, Kenji Nabeshima, Toshikazu Hada, Kazuya Higashino, Tumor markers in pleural effusion diagnosis Cancer. ,vol. 61, pp. 298- 302 ,(1988) , 10.1002/1097-0142(19880115)61:2<298::AID-CNCR2820610219>3.0.CO;2-U
Annalisa Siri, Barbara Carnemolla, Stephen Raffanti, Patrizia Castellani, Emma Balzano, Luciano Zardi, Fibronectin concentrations in pleural effusions of patients with malignant and non-malignant diseases Cancer Letters. ,vol. 22, pp. 1- 9 ,(1984) , 10.1016/0304-3835(84)90037-5
Matti Klockars, Pleural Fluid Lysozyme in Human Disease Archives of Internal Medicine. ,vol. 139, pp. 73- 77 ,(1979) , 10.1001/ARCHINTE.1979.03630380051018
Harold Levine, Diagnosis of Tuberculous Pleurisy by Culture of Pleural Biopsy Specimen Archives of Internal Medicine. ,vol. 126, pp. 269- 271 ,(1970) , 10.1001/ARCHINTE.1970.00310080075009
Peter H. Wiernik, Arthur A. Serpick, Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies The American Journal of Medicine. ,vol. 46, pp. 330- 343 ,(1969) , 10.1016/0002-9343(69)90036-9
M A Piras, C Gakis, M Budroni, G Andreoni, Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. BMJ. ,vol. 2, pp. 1751- 1752 ,(1978) , 10.1136/BMJ.2.6154.1751-A
Inma Ocaña, José M. Martinez-Vazquez, Rosa M. Segura, Tomás Fernandez-De-Sevilla, José A. Capdevila, Adenosine Deaminase in Pleural Fluids Chest. ,vol. 84, pp. 51- 53 ,(1983) , 10.1378/CHEST.84.1.51
Adrian O. Vladutiu, F. Wells Brason, Richard H. Adler, Differential Diagnosis of Pleural Effusions Chest. ,vol. 79, pp. 297- 301 ,(1981) , 10.1378/CHEST.79.3.297